|
|
 |
From
our beginnings in the early 1980s, Pharmascience's scientific capabilities
have grown tremendously...along with our zeal to take on new challenges.
We continuously reinvest over 14% of sales revenues towards R&D, and we are
committed to investing more in the future. We have a full spectrum of in-house
capabilities, starting in the lab where we formulate drug products and develop
testing methods. We take formulations from the lab right through to clinical
testing and regulatory approval.
|
 |
With
decades of experience and a proven track record behind us, Pharmascience
is familiar with the approval standards of TPD, FDA and the European
Union, and we meet these standards unerringly in all phases of product
development through final regulatory approval.
|
 |
Pharmascience
has formed R&D alliances with pharmaceutical companies and universities
both in Canada and abroad. Our partners have discovered we are more
than a company willing to share costs and risks. In Pharmascience,
they find a staff of scientific professionals with the background
and expertise to understand and work through the most complex issues.
They also find a creative partner that contributes significantly to
the entire development process -- from R&D, to approval, to marketing.
|
|
